Centro Integral en Reumatologia S.A de C.V /ID# 208346

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Psoriasis
• Psoriatic arthritis

Running trials

• Active, not recruiting

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

  NCT03675308· Phase 3· AbbVie· Source